Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Becker

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Leukemia|July 28, 2019
TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosisMilena Pantic, Dietmar Pfeifer, Silke Kapp-Schwoerer, et al.
Leukemia & Lymphoma|October 22, 2013
Up-regulation of RUNX2 in acute myeloid leukemia in a patient with an inherent RUNX2 haploinsufficiency and cleidocranial dysplasiaDominik Schnerch, Ekkehart Lausch, Heiko Becker, et al.
The Journal of Biological Chemistry|November 11, 2003
Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteinsPeter Kraiczy, Jens Hellwage, Christine Skerka, et al.
British Journal of Haematology|December 2, 2016
Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine)Michael Lübbert, Gabriele Ihorst, Philipp N Sander, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2025
Response to PD-1 inhibition in MMRd/MSS pancreatic ductal adenocarcinoma: the relevance of parallel testingHeike L Pahl, Silke Lassmann, Anne M Schultheis, et al.
Clinical Epigenetics|November 28, 2023
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk geneticsNora Rebeka Javorniczky, Olga Grishina, Inga Hund, et al.
Haematologica|September 2, 2018
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcomeJulia Stomper, Gabriele Ihorst, Stefan Suciu, et al.
Bone Marrow Transplantation|June 1, 2019
Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donorsAnezka Heumüller, Julius Wehrle, Juliane Stosch, et al.
Molecular Cancer|March 24, 2010
Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2Dirk Zboralski, Bettina Warscheid, Susanne Klein-Scory, et al.
Clinical Epigenetics|September 11, 2024
Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotypeJohanna Thomas, Usama-Ur Rehman, Helena Bresser, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Leukemia|July 28, 2019
TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosisMilena Pantic, Dietmar Pfeifer, Silke Kapp-Schwoerer, et al.
Leukemia & Lymphoma|October 22, 2013
Up-regulation of RUNX2 in acute myeloid leukemia in a patient with an inherent RUNX2 haploinsufficiency and cleidocranial dysplasiaDominik Schnerch, Ekkehart Lausch, Heiko Becker, et al.
The Journal of Biological Chemistry|November 11, 2003
Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteinsPeter Kraiczy, Jens Hellwage, Christine Skerka, et al.
British Journal of Haematology|December 2, 2016
Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine)Michael Lübbert, Gabriele Ihorst, Philipp N Sander, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2025
Response to PD-1 inhibition in MMRd/MSS pancreatic ductal adenocarcinoma: the relevance of parallel testingHeike L Pahl, Silke Lassmann, Anne M Schultheis, et al.
Clinical Epigenetics|November 28, 2023
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk geneticsNora Rebeka Javorniczky, Olga Grishina, Inga Hund, et al.
Haematologica|September 2, 2018
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcomeJulia Stomper, Gabriele Ihorst, Stefan Suciu, et al.
Bone Marrow Transplantation|June 1, 2019
Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donorsAnezka Heumüller, Julius Wehrle, Juliane Stosch, et al.
Molecular Cancer|March 24, 2010
Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2Dirk Zboralski, Bettina Warscheid, Susanne Klein-Scory, et al.
Clinical Epigenetics|September 11, 2024
Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotypeJohanna Thomas, Usama-Ur Rehman, Helena Bresser, et al.
Pageof 10